Blueprint (Bryan Johnson)
Last funding round
Bootstrapped — Bryan Johnson personal balance sheet
What they do in peptide space
Blueprint is Bryan Johnson's longevity protocol distributed as a consumer brand — supplement formulations, food kits, and protocol tracking. The thesis is that a curated, dose-published, third-party-tested set of supplements aligned with Johnson's published longevity protocol gives early adopters a turnkey way to follow the same regimen.
Included here because Blueprint sits at the intersection of editorial content (Johnson is also one of the most-followed longevity voices on /experts and /watch) and longevity-product commerce. The peptide-specific overlap is limited — Blueprint's product line is supplements + food, not peptides — but the company is a reference point for what consumer-side longevity branding looks like at scale.
Not publicly traded; Blueprint is operated as part of Johnson's personal brand and balance sheet.
Recent mentions
Coming soon — no editorial coverage or FDA alert mentioning Blueprint (Bryan Johnson) in our index yet. Items will surface here as the news / FDA cron pipelines ingest them.